TL;DR
This paper introduces NGF/CU, a novel nanoscale metal-organic framework loaded with nerve growth factor, designed to treat diabetic ulcers. By simultaneously scavenging reactive oxygen species (ROS) and promoting nerve regeneration, NGF/CU effectively accelerates wound healing and restores skin-nerve interaction, offering a promising new therapeutic strategy.
What Problem Does This Paper Address?
Diabetic ulcers (DUs) are a serious and common complication of diabetes, characterized by slow or non-healing wounds. The underlying pathology involves a complex interplay of factors, including impaired skin-nerve interaction due to diabetic peripheral neuropathy and an overabundance of reactive oxygen species (ROS). This creates a vicious cycle where ROS exacerbates inflammation and damages cells, further hindering the skin's natural repair mechanisms. Current treatments often focus on debridement and metabolic management but struggle with high recurrence rates and the risk of amputation. This paper addresses the critical need for a therapeutic approach that can simultaneously tackle the ROS-induced inflammation and the compromised nerve function characteristic of diabetic ulcers.
Methods
The researchers synthesized a nanoscale metal-organic framework, Ce-UiO-66 (CU), and loaded it with nerve growth factor (NGF) to create NGF/CU. The synthesis involved a hydrothermal method. Characterization techniques included transmission electron microscopy (TEM), elemental mapping, X-ray diffraction (XRD), and Fourier transform infrared (FT-IR) spectroscopy to confirm the structure and composition of CU and NGF/CU. The release kinetics of NGF from the framework were studied under different conditions.
To evaluate the therapeutic efficacy, the study employed a multi-pronged approach:
- In vitro studies:
- Cellular uptake: Inductively coupled plasma-mass spectrometry (SC-ICP-MS) was used to measure the internalization of NGF/CU by human umbilical vein endothelial cells (HUVECs) and human keratinocyte cells (HaCaTs).
- ROS scavenging and cell protection: Cell viability assays (CCK-8) and DCFH-DA staining were used to assess the protective effects of NGF/CU against ROS-induced damage in HUVECs, HaCaTs, and PC12 (nerve) cells. GSSG levels were also measured to evaluate oxidative stress.
- Anti-inflammatory effects: ELISA and immunofluorescence were used to measure the expression of pro-inflammatory (TNF-α, IL-6) and anti-inflammatory (IL-10) cytokines in LPS-stimulated RAW264.7 macrophages and BV2 microglia.
- Neuroendocrine regulation: RT-qPCR and ELISA were used to assess the expression of neuroendocrine markers like substance P (SP), cortisol (CORT), and insulin growth factor 1 (IGF1) in nerve-related cells and skin tissues.
- Cell proliferation and migration: Ki67 staining, CCK-8 assays, and scratch assays were used to evaluate the impact of NGF/CU on HUVEC and HaCaT proliferation and migration, particularly in co-culture systems with NGF-treated PC12 cells.
- In vivo studies:
- Diabetic ulcer model: A diabetic mouse model was established using streptozotocin (STZ) induction, followed by the creation of dorsal wounds.
- Wound healing assessment: Wound area, photographic documentation, epidermal thickness, and wound length were measured over time. Histological analysis (H&E and Masson Trichrome staining) was performed on wound tissues.
- Nerve regeneration: Immunofluorescence staining for neurofilament 200 (NF200) and β-III-tubulin (Tuj1) was used to assess peripheral nerve regeneration.
- Biocompatibility: Hemolysis assays and histological examination of major organs after intradermal injection were conducted to assess the safety of NGF/CU.
- Mechanism investigation: RNA sequencing (RNA-seq) was performed on skin tissues from treated mice to identify the underlying molecular mechanisms, followed by gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses.
Datasets
Not explicitly discussed as distinct datasets for training or evaluation in the context of machine learning. The study utilizes in vitro cell culture models (HUVECs, HaCaTs, PC12, RAW264.7, BV2) and an in vivo diabetic mouse model. The RNA sequencing data generated from these in vivo samples serves as a dataset for mechanistic analysis.
Key Insights and Ideas
- Synergistic Action: The combination of NGF and the ROS-scavenging MOF (CU) is crucial. While CU effectively reduces ROS and inflammation, NGF is essential for nerve repair and regeneration, and their combined effect is significantly greater than either component alone.
- Nerve-Neuroendocrine Axis: The study highlights the critical role of the skin's neuroendocrine system in wound healing. NGF/CU not only repairs damaged nerves but also appears to restore the function of this axis, leading to improved skin cell proliferation and overall healing.
- NF-κB Pathway Inhibition: NGF/CU effectively suppresses the NF-κB signaling pathway, a key mediator of inflammatory responses, thereby reducing the inflammatory burden in diabetic ulcers.
- Biocompatibility: The developed NGF/CU material demonstrates good biocompatibility, showing no significant cytotoxicity or adverse effects in various cell lines and in vivo organ examinations.
- Holistic Approach: The research emphasizes that effective treatment for diabetic ulcers requires a multifaceted approach that addresses both the oxidative stress and the compromised nerve function, rather than focusing on one aspect alone.
Key Results
- Wound Healing Acceleration: NGF/CU treatment led to significantly accelerated wound closure in diabetic mice, with wound closure rates of 99% by day 14, compared to 82% for the control group.
- Nerve Regeneration: Immunofluorescence analysis showed substantial regeneration of peripheral nerves (NF200 and Tuj1 staining) in the NGF/CU treated group, significantly outperforming CU or NGF alone.
- ROS Scavenging: NGF/CU effectively scavenged ROS in cell models, restoring cell viability to near-normal levels (around 100%) in H2O2-stimulated HUVECs and HaCaTs.
- Inflammation Reduction: NGF/CU significantly reduced pro-inflammatory cytokines (TNF-α, IL-6) and increased anti-inflammatory cytokine (IL-10) expression in LPS-stimulated cells.
- Neuroendocrine Marker Restoration: In nerve-related cells and skin tissues, NGF/CU treatment restored the levels of SP, CORT, and IGF1, which were diminished under inflammatory conditions.
- RNA-Seq Findings: Gene enrichment analysis revealed that NGF/CU downregulated ROS-related pathways and upregulated pathways associated with the neuroendocrine system, supporting the proposed mechanism.
Limitations and Future Work
- Specific Neuroendocrine Substances: While the study identified the restoration of the neuroendocrine system, the precise identity and roles of all secreted substances involved in this process require further investigation.
- Long-term Efficacy: While biocompatibility was assessed, long-term efficacy and potential side effects in chronic diabetic ulcer scenarios would benefit from further study.
- Clinical Translation: The study was conducted in animal models. Further research is needed to translate these findings into human clinical trials.
- Mechanism Refinement: While the NF-κB pathway and neuroendocrine system were identified, a more granular understanding of the specific molecular interactions and signaling cascades could be beneficial.
Summary updated